Catheter Precision's board has designated rights for up to 80,000 shares of Series C-4 convertible preferred stock, with 33,158 shares currently outstanding, due to raise capital.
Catheter Precision's board has designated rights for up to 80,000 shares of Series C-4 convertible preferred stock, with 33,158 shares currently outstanding, due to raise capital.